Clinical Trials Sponsored by Bard Electrophysiology

Total 1215 results

Electrophysiology Research Foundation

Recruiting

Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure (TAP-CHF)

Heart Failure | Atrial Fibrillation | Diastolic Heart Failure

United States, Germany, Switzerland
Brain Electrophysiology Laboratory Company

Unknown

Closed Loop TES for Enhancing Slow Wave Sleep

Insomnia | Sleep Disturbance

United States
Newmarket Electrophysiology Research Group Inc

Unknown

Persistent Atrial Fibrillation Ablation and Correlation to Quality of Life (LEARN-AF)

Atrial Fibrillation

Canada
Brain Electrophysiology Laboratory Company

Recruiting

Non-Invasive At-Home Sleep Therapy System

Sleep | Sleep Quality | Sleep Duration

United States
Brain Electrophysiology Laboratory Company

Completed

Electrical Synchronization of Slow Oscillations to Enhance Deep Sleep (ESSOTEDS)

Sleep | Sleep Hygiene

United States
Pacific Rim Electrophysiology Research Institute

Completed

ECGI in Patients With Persistent Atrial Fibrillation

Atrial Fibrillation

Thailand
Newmarket Electrophysiology Research Group Inc

Unknown

Effects of Mindfulness on Atrial Fibrillation

Atrial Fibrillation

Canada
Electrophysiology Research Foundation
Axio Research Corporation

Terminated

EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation (ENTICED-AF)

Atrial Fibrillation

United States
Newmarket Electrophysiology Research Group Inc
Medtronic

Completed

Efficiency Study Evaluating the Use of PVAC Catheter Technology for Performing Ablation in Pts With Atrial Fibrillation (CAPCOST)

Atrial Fibrillation

Canada
C. R. Bard
Bard Ltd

Completed

Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

Critical Limb Ischemia

United States, Japan, Austria, Canada, Switzerland, Italy, Belgium, Germany
C. R. Bard
Bard Ltd

Completed

Lutonix Global SFA Registry

Peripheral Artery Disease

Germany, United Kingdom, Greece, Switzerland, Austria, Poland, Spain, Italy, France, Belgium
Bard College

Not yet recruiting

Positive Feedback vs. No-Feedback Games for Behavioral Change

Major Depressive Disorder | Low Mood

United States
Newmarket Electrophysiology Research Group Inc
Biosense Webster, Inc.

Withdrawn

Trial Comparing Ablation With Medical Therapy in Patients With Ventricular Tachycardia (VeTAMed)

Coronary Artery Disease | Ventricular Tachycardia
Pacific Rim Electrophysiology Research Institute
University of Bordeaux

Recruiting

VF Mapping in Brugada and Early Repolarization Syndromes

Early Repolarization Syndrome | Brugada Syndrome

Thailand
C. R. Bard

Recruiting

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System (CONNECT-AV)

Arteriovenous Fistula | End-stage Renal Disease | Kidney Disease, End-Stage

United States
C. R. Bard

Active, not recruiting

Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

Arteriovenous Fistula

United States
C. R. Bard

Terminated

The Pristine Post-Market Study

End Stage Renal Disease | Kidney Failure, Chronic | Hemodialysis Access Failure | Hemodialysis Complication | Central Venous Catheter Related Bloodstream Infection | Hemodialysis Catheter Infection

United States
C. R. Bard

Completed

Lutonix® Global AV Registry Investigating Lutonix Drug Coated Balloon for Treatment of Native and Synthetic AV Fistulae (AVR)

Arteriovenous Fistula

United Kingdom, Singapore, France, Italy, Germany, Switzerland, Greece, Austria, Poland, Portugal, Saudi Arabia, Taiwan, Turkey
C. R. Bard

Terminated

The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation (WAVE-Global)

Chronic Kidney Diseases | End Stage Kidney Disease | Kidney Disease, Chronic | Kidney Failure | AV Fistula | Kidney Insufficiency | Fistulas Arteriovenous

Switzerland, Belgium, Greece
C. R. Bard

Completed

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft (AVeNEW)

Restenosis | Stenosis

Australia, Germany, Austria, United States, Belgium, New Zealand, Netherlands, Switzerland
C. R. Bard

Completed

A Prospective Trial of a Bio-absorbable Mesh in Challenging Laparoscopic Ventral or Incisional Hernia Repair (ATLAS)

Hernia, Ventral | Incisional Hernia

United States
C. R. Bard

Completed

Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae

Arteriovenous Fistula

United States
C. R. Bard

Completed

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA) (AVeVA)

Restenosis | Stenosis

United States
C. R. Bard

Completed

Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis (SFA ISR)

Restenosis | Femoral Artery Occlusion | Femoral Artery Stenosis

United States
C. R. Bard

Completed

Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent System (REALITY III)

Peripheral Arterial Disease | Intermittent Claudication

Germany
C. R. Bard

Terminated

Electrocardiogram (ECG) Guided Peripherally Inserted Central Catheter (PICC) Placement

Primary Focus: Adult Subjects Who Require PICC Placement

United States
C. R. Bard

Terminated

Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter

Vascular Access Complication

United States
C. R. Bard

Completed

Progel Vascular Sealant

Aortic Valve Stenosis | Aortic Valve Disorder | Aneurysm of Ascending Aorta | Bicuspid Valve Disorder

United States
C. R. Bard

Completed

Post-Approval Study for the FLAIR Endovascular Stent Graft (RENOVA)

Stenosis of Vascular Prosthetic Devices, Implants and Grafts

United States
C. R. Bard

Completed

AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In General Nursing Use

Vascular Access Complication

United States
C. R. Bard

Completed

Study to Assess Electrocardiogram Waveforms Produced Through the Utilization of the Sherlock 3CG™ Tip Confirmation System (MODUS)

Indication for Peripheral Intravenous Catheterization

United States
C. R. Bard

Completed

Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP) (NASCENT)

Respiratory Failure

United States
C. R. Bard

Completed

De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting for Treatment of Coronary De Novo Lesions

Coronary Artery Stenosis

Netherlands
C. R. Bard

Completed

Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation (True™Flow)

Aortic Valve Stenosis

Germany
C. R. Bard

Completed

FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis (RESCUE)

Restenosis

United States
C. R. Bard

Terminated

Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters (DISTAL)

Cancer

United States
C. R. Bard

Completed

A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System

Pulmonary Embolism

United States
C. R. Bard

Completed

GENESIS Feasibility Study of the BARD Over-the-Wire Mesh Ablation System for the Treatment of Paroxysmal Atrial Fibrillation (GENESIS)

Paroxysmal Atrial Fibrillation

Canada, Germany, United Kingdom
C. R. Bard

Completed

RF Ablation of Atrial Fibrillation

Atrial Fibrillation

United States
C. R. Bard

Terminated

Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation (MAGELLAN)

Paroxysmal Atrial Fibrillation

United States
C. R. Bard

Completed

Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. (EVEREST)

Pulmonary Embolism | Venous Thromboembolic Disease
C. R. Bard

Completed

Pivotal Study for the FLAIR Endovascular Stent Graft

Stenoses

United States
C. R. Bard

Completed

Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon

Arterial Occlusive Diseases | Peripheral Arterial Disease | Peripheral Vascular Diseases

United States
C. R. Bard

Active, not recruiting

Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries (PREVISION)

Peripheral Arterial Disease | Peripheral Artery Disease | Stenosis Artery

Australia, New Zealand, Singapore
C. R. Bard

Completed

Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias

Incisional Hernia

United States
C. R. Bard

Terminated

SHERLOCK 3CG™ Diamond Tip Confirmation System (MODUS II)

Bundle-Branch Block | Tachycardia | Atrioventricular Block | Atrial Flutter | Premature Ventricular Contraction | Premature Atrial Contraction | Indication for Peripheral Intravenous Catheterization | Premature Junctional Contraction

United States, Australia
C. R. Bard

Completed

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

Lung Cancer | Lung Tumor

United States
C. R. Bard

Completed

BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR)

Peripheral Vascular Disease | Venous Disease | May-Thurner Syndrome | Iliofemoral Occlusive Disease

United States, Australia, Germany, Ireland, Netherlands, Spain, United Kingdom
C. R. Bard

Completed

BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease (BOLSTER)

Peripheral Vascular Disease | Peripheral Artery Disease | Arterial Occlusive Disease

United States, Germany, New Zealand
C. R. Bard

Completed

Study of Phasix™ Mesh for VHWG Grade 3 Midline Hernia Repair

Hernia | Hernia, Abdominal | Hernia, Incisional

Belgium, Netherlands, Denmark, France, Italy, United Kingdom, Austria, Germany

Clinical Trials Sponsored by Bard Electrophysiology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations